Published in Patient Educ Couns on November 01, 2001
The role of chemotherapy at the end of life: "when is enough, enough?". JAMA (2008) 3.31
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax (2004) 2.22
A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer. J Support Oncol (2011) 1.38
Preference assessment of recruitment into a randomized trial for adolescent idiopathic scoliosis. J Bone Joint Surg Am (2008) 0.99
Differential patient-caregiver opinions of treatment and care for advanced lung cancer patients. Soc Sci Med (2010) 0.96
Patients' preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer. Eur J Health Econ (2014) 0.89
Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced population. BMC Cancer (2013) 0.77
Patient, doctor, disease, and informed consent. Multidiscip Respir Med (2011) 0.75
How much survival benefit is necessary for breast cancer patients to opt for adjuvant chemotherapy? Results from a Chilean survey. Ecancermedicalscience (2014) 0.75
Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals. Int J Clin Oncol (2014) 0.75
Decisions for lung cancer chemotherapy: the influence of physician and patient factors. Support Care Cancer (2011) 0.75
High-performance lithium-ion anodes using a hierarchical bottom-up approach. Nat Mater (2010) 3.25
Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol (1998) 3.24
What questions do patients with curable prostate cancer want answered? Med Decis Making (2000) 2.93
Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys (1994) 2.77
Do minutes count? Consultation lengths in general practice. J Health Serv Res Policy (1998) 2.23
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1993) 2.22
The effect of single prenatal and natal complications upon the development of children of mature birthweight. Pediatrics (1969) 2.04
Perception of quantitative information for treatment decisions. Med Decis Making (2000) 2.04
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01
Does a centralized radiotherapy system provide adequate access to care? J Clin Oncol (1997) 1.90
Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer (2001) 1.90
Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study. Radiother Oncol (1990) 1.88
Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol (1999) 1.81
A population-based study of malignant spinal cord compression in Ontario. Clin Oncol (R Coll Radiol) (2003) 1.60
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer. Br J Cancer (1986) 1.53
Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys (1999) 1.43
Intensity-modulated radiotherapy in the treatment of breast cancer. Clin Oncol (R Coll Radiol) (2012) 1.42
Decision analysis in locally advanced non-small-cell lung cancer: is it useful? J Clin Oncol (1997) 1.40
Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. Proc Natl Acad Sci U S A (1999) 1.37
Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys (1999) 1.36
Ethical problems in clinical research: the need for empirical studies of the clinical trials process. J Chronic Dis (1986) 1.36
A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. J Natl Cancer Inst (1983) 1.35
A comparison of published head and neck stage groupings in carcinomas of the oral cavity. Head Neck (2001) 1.34
Communicating quality of life information to cancer patients: a study of six presentation formats. J Clin Oncol (2005) 1.31
Ribosomes in thiostrepton-resistant mutants of Bacillus megaterium lacking a single 50 S subunit protein. J Mol Biol (1979) 1.29
Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys (2001) 1.27
The influence of fish cage aquaculture on pelagic carbon flow and water chemistry in tidally dominated mangrove estuaries of peninsular Malaysia. Mar Environ Res (2003) 1.26
Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol (2001) 1.25
Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord (1997) 1.24
An assessment of US and Canadian smoking reduction objectives for the year 2000. Am J Public Health (1998) 1.22
Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol (1997) 1.22
Time spent in hospital in the last six months of life in patients who died of cancer in Ontario. J Clin Oncol (2002) 1.21
Use of femoral venous catheters in critically ill adults: prospective study. Crit Care Med (1991) 1.20
Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol (1992) 1.20
Cancer Care Ontario Colonoscopy Standards: standards and evidentiary base. Can J Gastroenterol (2007) 1.20
Waiting times for cancer surgery in Ontario: 1984-2000. Clin Oncol (R Coll Radiol) (2006) 1.20
The role of palliative thoracic radiotherapy in non-small cell lung cancer. Can J Oncol (1996) 1.20
University of Alberta norms of relative meaning frequency for 566 homographs. Mem Cognit (1994) 1.20
Lung cancer treatment decisions: patients' desires for participation and information. Psychooncology (2000) 1.19
Do doctors know when their patients don't? A survey of doctor-patient communication in lung cancer. Lung Cancer (1997) 1.17
The impact of nursing grade on the quality and outcome of nursing care. Health Econ (1995) 1.16
Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol (1994) 1.13
A comparison of 399 open and 568 laparoscopic gastric bypasses performed during a 4-year period. Surg Endosc (2007) 1.13
Non-small cell lung cancer: how oncologists want to be treated. Int J Radiat Oncol Biol Phys (1987) 1.12
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res (1992) 1.12
Supportive care management of brain metastases: what is known and what we need to know. Conference proceedings of the National Cancer Institute of Canada (NCIC) Workshop on Symptom Control in Radiation Oncology. Clin Oncol (R Coll Radiol) (2003) 1.09
Associations between socioeconomic status and cancer survival: choice of SES indicator may affect results. Ann Epidemiol (2006) 1.07
Circulatory, plasma catecholamine, cortisol, lipid, and psychological responses to a real-life stress (third molar extractions): effects of diazepam sedation and of inclusion of epinephrine with the local anesthetic. Psychosom Med (1982) 1.06
Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol) (2006) 1.05
Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med (1998) 1.05
Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer (2001) 1.02
Factors associated with referral to medical oncology and subsequent use of adjuvant chemotherapy for non-small-cell lung cancer: a population-based study. Curr Oncol (2013) 1.02
Site of action of clomiphene and its use as a test of pituitary function. J Obstet Gynaecol Br Commonw (1971) 1.01
Dynamic illusion effects in a reaching task: evidence for separate visual representations in the planning and control of reaching. J Exp Psychol Hum Percept Perform (2001) 1.01
Late onset in dysferlinopathy widens the clinical spectrum. Neuromuscul Disord (2008) 1.01
The effectiveness of topical diclofenac for lateral epicondylitis. Clin J Sport Med (1998) 1.01
Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1999) 1.01
What prostate cancer patients should know: variation in professionals' opinions. Radiother Oncol (1998) 0.99
A comparison of published head and neck stage groupings in carcinomas of the tonsillar region. Cancer (2001) 0.98
Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2000) 0.97
End-of-life decision making in the seriously ill hospitalized patient: an organizing framework and results of a preliminary study. J Palliat Care (2000) 0.96
Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles? J Clin Epidemiol (2001) 0.96
Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer (2000) 0.95
Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. J Clin Oncol (1995) 0.95
The consultation to develop a national strategy for cancer staging in Canada. Cancer Prev Control (1998) 0.95
A real-time audit of radiation therapy in a regional cancer center. Int J Radiat Oncol Biol Phys (1999) 0.94
Herpes simplex virus infection in rabbit eye. Arch Ophthalmol (1972) 0.94
Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys (2000) 0.92
Osteochondritis dissecans of the knee; long-term clinical outcome following arthroscopic debridement. Knee (2007) 0.92
Enzyme-linked immunosorbent assay for the diagnosis of bovine leukosis: comparison with the agar gel immunodiffusion test approved by the Canadian Food Inspection Agency. Can J Vet Res (2000) 0.92
Monitoring outcomes in routine practice: defining appropriate measurement criteria. J Eval Clin Pract (1996) 0.92
Induction of human neonatal pulmonary fibroblast cytokines by hyperoxia and Ureaplasma urealyticum. Clin Infect Dis (1993) 0.91
Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer. J Clin Oncol (2001) 0.90
Using a treatment-tradeoff method to elicit preferences for the treatment of locally advanced non-small-cell lung cancer. Med Decis Making (1998) 0.90
Teams and seams: skill mix in primary care. J Adv Nurs (1998) 0.90
Cancer patients' preferences for communicating clinical trial quality of life information: a qualitative study. Qual Life Res (2003) 0.90
Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann Neurol (2001) 0.89
Effect of complexed synthetic RNA analogues on herpes simplex virus infection in rabbit cornea. Am J Ophthalmol (1970) 0.89
Neonatal immunity develops in a transgenic TCR transfer model and reveals a requirement for elevated cell input to achieve organ-specific responses. J Immunol (2001) 0.89
Cellular heterogeneity in human ovarian carcinoma studied by density gradient fractionation. Stem Cells (1982) 0.89
Motor adaptation to an optical illusion. Exp Brain Res (2001) 0.89
Multi-modal antigen specific therapy for autoimmunity. Int Rev Immunol (2001) 0.88
Comparing the predictive value of neural network models to logistic regression models on the risk of death for small-cell lung cancer patients. Eur J Cancer Care (Engl) (2006) 0.88
Cellular heterogeneity in normal human urothelium: an analysis of optical properties and lectin binding. J Histochem Cytochem (1986) 0.87
Density/volume analysis in the study of cellular heterogeneity in human ovarian carcinoma. Br J Cancer (1982) 0.87
The management and outcome of bladder carcinoma in Ontario, 1982-1994. Cancer (2000) 0.87